- Home
- PRQR vs LGI Comparison
PRQR vs LGI Comparison
Compare PRQR & LGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRQR
- LGI
- Stock Information
- Founded
- PRQR 2012
- LGI 2004
- Country
- PRQR Netherlands
- LGI United States
- Employees
- PRQR N/A
- LGI N/A
- Industry
- PRQR Biotechnology: Pharmaceutical Preparations
- LGI
- Sector
- PRQR Health Care
- LGI
- Exchange
- PRQR Nasdaq
- LGI Nasdaq
- Market Cap
- PRQR 179.1M
- LGI 210.5M
- IPO Year
- PRQR 2014
- LGI N/A
- Fundamental
- Price
- PRQR $2.13
- LGI $16.91
- Analyst Decision
- PRQR Strong Buy
- LGI
- Analyst Count
- PRQR 8
- LGI 0
- Target Price
- PRQR $8.88
- LGI N/A
- AVG Volume (30 Days)
- PRQR 362.3K
- LGI 41.1K
- Earning Date
- PRQR 08-07-2025
- LGI 01-01-0001
- Dividend Yield
- PRQR N/A
- LGI 7.10%
- EPS Growth
- PRQR N/A
- LGI N/A
- EPS
- PRQR N/A
- LGI N/A
- Revenue
- PRQR $21,212,711.00
- LGI N/A
- Revenue This Year
- PRQR N/A
- LGI N/A
- Revenue Next Year
- PRQR N/A
- LGI N/A
- P/E Ratio
- PRQR N/A
- LGI N/A
- Revenue Growth
- PRQR 85.91
- LGI N/A
- 52 Week Low
- PRQR $1.07
- LGI $12.66
- 52 Week High
- PRQR $4.62
- LGI $16.68
- Technical
- Relative Strength Index (RSI)
- PRQR 64.73
- LGI 70.74
- Support Level
- PRQR $1.89
- LGI $15.97
- Resistance Level
- PRQR $2.54
- LGI $16.96
- Average True Range (ATR)
- PRQR 0.14
- LGI 0.19
- MACD
- PRQR 0.01
- LGI 0.04
- Stochastic Oscillator
- PRQR 43.06
- LGI 94.95
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.
About LGI Lazard Global Total Return and Income Fund
Lazard Global Total Return & Inc Fd Inc is a United States-based diversified, closed-end management investment company. Its investment objective is total return consisting of capital appreciation and income. The fund's portfolio of investments consists of different sector investments such as consumer staples, financials, consumer discretionary, healthcare, materials, sovereign debt and others.